Bioceres Crop Solutions (NASDAQ:BIOX) Shares Up 4.8% – Here’s What Happened

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) shares rose 4.8% on Monday . The company traded as high as $0.3989 and last traded at $0.3897. Approximately 283,297 shares were traded during trading, a decline of 82% from the average daily volume of 1,536,495 shares. The stock had previously closed at $0.3720.

Analyst Ratings Changes

Several research firms recently issued reports on BIOX. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research note on Friday, January 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.00.

Bioceres Crop Solutions Trading Up 4.8%

The stock has a market cap of $24.64 million, a P/E ratio of -0.10 and a beta of 0.53. The firm’s 50 day simple moving average is $0.72 and its two-hundred day simple moving average is $1.31. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Friday, March 13th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%.The business had revenue of $73.67 million during the quarter, compared to the consensus estimate of $104.55 million. As a group, equities research analysts predict that Bioceres Crop Solutions Corp. will post -0.05 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently bought and sold shares of the business. Bank of America Corp DE boosted its stake in Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares during the period. Jones Financial Companies Lllp raised its position in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the period. Ardsley Advisory Partners LP lifted its holdings in shares of Bioceres Crop Solutions by 4.7% in the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock worth $4,441,000 after purchasing an additional 45,000 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Bioceres Crop Solutions in the 2nd quarter worth approximately $202,000. Finally, PDT Partners LLC boosted its position in Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after purchasing an additional 10,449 shares during the period. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.